1. Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16–29 years. Issue 19 (26th April 2022) Authors: Funk, Patrick R.; Yogurtcu, Osman N.; Forshee, Richard A.; Anderson, Steve A.; Marks, Peter W.; Yang, Hong Journal: Vaccine Issue: Volume 40:Issue 19(2022) Page Start: 2781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗